Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2009-11-2
pubmed:abstractText
Correction of a defective gene is a promising approach for both basic research and clinical gene therapy. However, the absence of site-specific targeting and the low efficiency of homologous recombination in human cells present barriers to successful gene targeting. In an effort to overcome these barriers, we utilized triplex-forming oligonucleotides (TFOs) conjugated to a DNA interstrand crosslinking (ICL) agent, psoralen (pTFO-ICLs), to improve the gene targeting efficiency at a specific site in DNA. Gene targeting events were monitored by the correction of a deletion on a recipient plasmid with the homologous sequence from a donor plasmid in human cells. The mechanism underlying this event is stimulation of homologous recombination by the pTFO-ICL. We found that pTFO-ICLs are efficient in inducing targeted gene conversion (GC) events in human cells. The deletion size in the recipient plasmid influenced both the recombination frequency and spectrum of recombinants; i.e. plasmids with smaller deletions had a higher frequency and proportion of GC events. The polarity of the pTFO-ICL also had a prominent effect on recombination. Our results suggest that pTFO-ICL induced intermolecular recombination provides an efficient method for targeted gene correction in mammalian cells.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-10064704, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-10206960, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-10629056, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-10882712, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-10900269, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11106642, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11459982, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11516927, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11812847, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11884621, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-11905724, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-12461167, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-1303270, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-15375217, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-15891767, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-16569514, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-16731047, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-17669695, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-18006494, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-18628293, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-18787700, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-18996898, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-19468048, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-2003222, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-2411210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-2555716, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-2708342, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-2943972, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-3007275, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-3161076, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-3293213, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-3523485, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-3534882, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-4577788, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-6281782, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-6297747, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-6380756, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-6752694, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-7026973, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-7528895, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-7548210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8114699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8159731, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8284208, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8420966, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8533154, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8596475, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8643590, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8943337, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-8972207, http://linkedlifedata.com/resource/pubmed/commentcorrection/19726585-9683673
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1362-4962
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6378-88
pubmed:dateRevised
2010-9-27
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Targeted gene conversion induced by triplex-directed psoralen interstrand crosslinks in mammalian cells.
pubmed:affiliation
Department of Carcinogenesis, University of Texas MD Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural